Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9Q03

Cryo-EM structure of ternary complex BCL6-CRBN-DDB1 with BCL6-760 (LDD, local refined)

This is a non-PDB format compatible entry.
Summary for 9Q03
Entry DOI10.2210/pdb9q03/pdb
EMDB information72086
DescriptorB-cell lymphoma 6 protein, Protein cereblon, ZINC ION, ... (4 entities in total)
Functional Keywordscereblon, bcl6, ldd, degrader, e3, ligase
Biological sourceHomo sapiens (human)
More
Total number of polymer chains3
Total formula weight87226.36
Authors
Zhu, J.,Fang, W.,Pagarigan, B. (deposition date: 2025-08-12, release date: 2025-10-15, Last modification date: 2025-11-05)
Primary citationShunatona, H.P.,Holmberg Douglas, N.,Rhodes, J.,Thomas, W.,Da Silva, D.,Gamez, J.,Groza, M.,Christoforou, A.,Zhu, J.,Johnson, S.,Dodd, D.,Huang, D.,Griffin, J.,Miseo, G.,Whitefield, B.,Weiss, D.,Rader, J.,Kuzu, E.,Leisten, J.,Del Rosario, J.,Shi, L.,Matyskiela, M.,Chamberlain, P.P.,Belmont, P.,Alexander, M.,Zapf, C.W.,Groocock, L.,Mortensen, D.S.
Discovery of Potent and Selective BCL6 Ligand-Directed Degrader (LDD), BCL6-760.
J.Med.Chem., 68:21502-21519, 2025
Cited by
PubMed Abstract: The discovery of a potent and selective BCL6 ligand-directed degrader (LDD), BCL6-760 () is described. Through structure-activity relationships, the most potent heterobifunctional degraders of BCL6 were found to be those containing short aminopiperidine linkers in combination with an indazole-based cereblon (CRBN)-binding moiety (CBM). In vitro ADME profiling of potent molecules identified BCL6-760 as an ideal molecule for use in in vivo experiments due to its good passive permeability, solubility, and microsomal stability. Mechanistic studies confirmed that BCL6 degradation is CRBN mediated, and proteomic assessment indicates a clean and selective degradation profile. BCL6-760 exhibited good oral mouse PK and was capable of penetrant and sustained PD effects. At 60 mg/kg BID dosing, BCL6-760 achieves >90% BCL6 reduction and leads to an overall 64% tumor volume reduction in an OCI-LY-1 mouse xenograft efficacy model.
PubMed: 41055242
DOI: 10.1021/acs.jmedchem.5c01645
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.15 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon